BioAge Labs, Inc. 8-K

What Happened
BioAge Labs, Inc. announced and filed a press release on March 24, 2026 reporting its financial results for the year ended December 31, 2025. The press release is attached to the Form 8‑K as Exhibit 99.1. In addition, the company updated its corporate investor presentation and posted the deck to the Investors section of its website (https://ir.bioagelabs.com/).

Key Details

• Press release announcing year‑end 2025 financial results dated March 24, 2026 (attached as Exhibit 99.1 to the 8‑K).
• Reporting period: year ended December 31, 2025.
• Company updated its corporate deck and made it available on its investor relations website: https://ir.bioagelabs.com/.
• Form 8‑K signed and filed by Dov Goldstein, M.D., Chief Financial Officer, dated March 24, 2026.

Why It Matters
This filing delivers the company’s latest annual financial results and refreshed investor presentation, which investors should review to assess BioAge’s recent performance, revenue/earnings trends, and strategic updates for 2026. The 8‑K itself does not include the detailed financial line items in the filing text—investors should read the attached press release (Exhibit 99.1) and the updated corporate deck on the IR site for the full figures and management commentary. No other material events (e.g., executive changes, mergers, or bankruptcy filings) were disclosed in this report.